EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward

Karolina Okła

Cells · 22.07.2023 · 12 (14) · 1912

DOI: 10.3390/cells12141912 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 22.07.2023. Verfasst von Karolina Okła. Beteiligte Einrichtung: The First Department of Oncologic Gynecology and Gynecology, Medical University of Lublin, 20-081 Lublin, Poland. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Ovarian Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid-derived suppressor cells (MDSCs) play a significant role in the immune system and have been extensively studied in cancer. MDSCs are a heterogeneous population of myeloid cells that accumulate in the tumor microenvironment. Consequently, the high abundance of these cells often leads to immunosuppression, tumor growth, treatment failure, and poor prognosis. Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female genital tract. Currently, there is a lack of effective clinical strategies for the treatment of ovarian cancer. Although several studies underline the negative role of human MDSCs in ovarian cancer, this topic is still understudied. The works on MDSCs are summarized here, along with an explanation of why focusing on these cells would be a promising approach for treating ovarian cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid-Derived Suppressor CellsOvarian NeoplasmsFemaleHumansMyeloid CellsImmunosuppression TherapyImmune ToleranceTumor Microenvironment

Stichwörter der Autor:innen

CAR-MMDSCsTMEimmunotherapymyeloid-derived suppressor cellsovarian cancertherapy resistance

Autor:innen und Institutionen

  • The First Department of Oncologic Gynecology and Gynecology, Medical University of Lublin, 20-081 Lublin, Poland.
  • Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA.

Förderung

  • National Science Centre

Zitieren

APA

Okła, K. (2023). Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward. Cells, 12(14), 1912. https://doi.org/10.3390/cells12141912

Vancouver

Okła K. Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward. Cells. 2023;12(14):1912. doi:10.3390/cells12141912

BibTeX
@article{Oka2023,
  author = {Okła, Karolina},
  title = {Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {14},
  pages = {1912},
  doi = {10.3390/cells12141912}
}
Kostenlos starten →